MIR — Mirion Technologies, Inc. stock price, charts and financials

QT18Mirion Technologies, Inc.

Mirion Technologies, Inc. (NYSE: MIR) is a Industrials company in the Industrial - Machinery industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
16.17
+0.49+3.13%
MIRQT18Mirion Technologies, Inc.·NYSE
16.17+3.13%
News
Up 3.1% — Perma-Fix and Mirion Technologies Form Strategic Partnership for DOE and Federal Nuclear Cleanup Opportunities (globenewswire.com).
Medium confidence
TA
Loading chart...
Signal & projected range
Earnings big beat — drift (PEAD)Historical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.
Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
Snapshot
Index-P/E179.67EPS (ttm)0.09Insider Own33.71%Shs Outstand244.66MPerf Week-3.69%
Market Cap3.96BForward P/E24.75EPS next Y0.65Insider Trans-0.01%Shs Float223.97MPerf Month-4.38%
Enterprise Value4.75BPEG8.69EPS next Q0.13Inst Own-Short Float15.47%Perf Quarter-19.79%
Income25.00MP/S3.86EPS this Y500.12%Inst Trans-Short Ratio8.54Perf Half Y-35.14%
Sales1.02BP/B2.11EPS next Y20.97%ROA0.70%Short Interest34.65MPerf YTD-30.96%
Book/sh7.66P/C9.24EPS next 5Y20.67%ROE1.33%52W High30.28 -46.60%Perf Year-18.58%
Cash/sh1.75P/FCF26.79EPS past 3/5Y-ROIC1.41%52W Low14.11 14.60%Perf 3Y117.63%
Dividend Est.-EV/EBITDA22.22Sales past 3/5Y8.81% -Gross Margin48.00%Volatility8.17% 4.92%Perf 5Y61.38%
Dividend TTM-EV/Sales4.64EPS Y/Y TTM150.00%Oper. Margin5.32%ATR (14)0.87Perf 10Y-
Dividend Ex-Date-Quick Ratio2.63Sales Y/Y TTM19.05%Profit Margin2.39%RSI (14)48.11Recom2.11
Dividend Gr. 3/5Y-Current Ratio3.20EPS Q/Q9.09%SMA200.15%Beta1.06Target Price25.80
Payout0.00%Debt/Eq0.64Sales Q/Q19.73%SMA50-4.93%Rel Volume1.07Prev Close15.68
Employees3,281LT Debt/Eq0.64EarningsOct 27SMA200-23.96%Avg Volume4.18MPrice16.17
IPO DateAug 20, 2020Option/ShortYes / YesEPS/Sales Surpr.16.03% -0.93%Net Debt/EBITDA3.82Volume4,474,047Change3.13%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-30-26ReiteratedNorthland SecuritiesOutperform$29$24
Jul-29-26ReiteratedGoldman SachsBuy$25$23
Jul-13-26ReiteratedMorgan StanleyEqual Weight$27$25
Jul-10-26ReiteratedGoldman SachsBuy$29$25
May-04-26ReiteratedEvercore ISI GroupOutperform$29$28
Mar-11-26ReiteratedMorgan StanleyEqual Weight$29$27
Feb-13-26ReiteratedRobert W. Baird$30$29
Feb-12-26ReiteratedGoldman SachsBuy$34$29
Jan-23-26InitiatedMorgan StanleyEqual Weight$29
Nov-25-25InitiatedEvercore ISIOutperform$29
Latest News
Aug-04-26
Aug-03-26
Jul-30-26
Jul-29-26
Jul-28-26
Jul-27-26
Jul-21-26
Jul-20-26
Jul-13-26
Jul-10-26
Jul-06-26
Jun-29-26
Company

Mirion Technologies, Inc., established in 2005 and formerly known as Global Monitoring Systems, Inc. until its name change in January 2006, is based in Atlanta, Georgia. The company specializes in providing a comprehensive suite of specialized solutions for radiation detection, measurement, analysis, and monitoring. Its operations span a wide international footprint, covering countries such as the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, and Japan. The business is organized into two distinct operating segments: Medical and Industrial. The Medical segment delivers critical solutions aimed at enhancing patient safety and treatment accuracy within healthcare environments. Offerings here include quality assurance and dosimetry tools for radiation oncology, specialized patient safety systems for diagnostic imaging and radiation therapy centers, and precision calibration and verification solutions for medical imaging and treatment accuracy. Furthermore, it supplies radionuclide therapy products, which encompass shielding, handling equipment, dedicated medical imaging furniture, and rehabilitation aids for nuclear medicine applications. This segment fundamentally supports advancements in medical diagnostics, cancer treatment, professional safety for practitioners, and patient recovery. Conversely, the Industrial segment addresses vital requirements in radiation safety, measurement, and analysis across non-medical industries. It furnishes clients with personal radiation detection devices, identification equipment, and advanced analytical instrumentation. Mirion's extensive product and solution portfolio includes a variety of items such as nuclear medicine preparations, personal dosimeters, contamination and clearance monitoring systems, and sophisticated reactor instrumentation and control equipment. They also provide both medical and industrial imaging systems along with their related accessories, in addition to specialized instruments for alpha spectroscopy, alpha/beta counting, and gamma spectroscopy detector systems. Supplementary offerings include electrical penetration components, cancer diagnostic tools, software solutions, and a range of other services. Mirion serves a broad and varied clientele across numerous sectors. This includes healthcare providers like hospitals, clinics, urgent care facilities, dental and veterinary offices, and specialized radiation treatment centers, as well as original equipment manufacturers (OEMs) for radiation therapy. Beyond healthcare, their customers extend to research laboratories, military organizations, governmental agencies, various industrial enterprises, power and utility companies, reactor design firms, and nuclear power plants (NPPs).

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
6/30/2018
Total Revenue1,0259258618017186680440444
Cost of Goods Sold Incl. D&A5344874594444013840252276
Gross Profit4924394023573172840188168
Selling, General and Administrative Excl. Other3983483383393572682145154
Research and Development40393532303601419
Other Operating Expense-104722849010
Operating Income555225-22-298-69-229-5
Interest Expense344258624359000
Unusual Expense
Non-Operating Income (Expense)1223-1-2134-101-43-155-136
Net Income Before Taxes3033-34-105-307-228-46-126-140
Income Taxes433-7-18-50-4-37
Consolidated Net Income2529-36-97-277-222-45-122-104
Net Income From Continuing Operations2630-37-99-288-223-45-122-104
Net Income2529-36-97-277-222-45-122-104
EPS (Recurring)0.100.13-0.18-0.49-1.53-0.61-0.480.00-0.00
EPS (Basic, Before Extraordinaries)0.100.13-0.18-0.49-1.53-0.61-0.480.00-0.00
EPS (Diluted)0.090.11-0.18-0.49-1.53-0.61-0.480.00-0.00
EBITDA21421317914910493699872
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio179.67212.91
Price To Sales Ratio3.875.824.152.511.673.26
Gross Margin48.0047.4646.6944.5744.1542.5142.7337.84
Operating Margin5.375.622.90-2.75-41.50-10.336.59-1.13
Net Margin2.443.14-4.18-12.11-38.58-33.23-27.73-23.42
Shares Outstanding2452302051961812081452095
Market Capitalization3,9625,3873,5772,0091,1962,1781,581
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$32.03$27.09$22.16$17.23$12.29 Close Price0.00M2.87M5.74M8.61M11.48MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Moore Christopher A.Chief Accounting Officer (PAO)May 07 '26Sale19.648,400164,97622,157May 08
Kingsley Lawrence DDirectorDec 10 '25Sale24.73350,0008,654,8003,509,075Dec 12
Kingsley Lawrence DDirectorNov 21 '25Sale23.83300,0007,148,4003,900,000Nov 21
Eloy LoicNuclear & Safety PresidentNov 11 '25Sale27.2445,0001,225,68397,770Nov 12
Lee EmmanuelleChief Legal OfficerNov 10 '25Sale27.4112,500342,64384,640Nov 12
Schopfer BrianChief Financial OfficerNov 06 '25Sale27.65100,0002,765,420904,432Nov 10
Logan Thomas DChief Executive OfficerAug 12 '25Sale21.79175,0003,813,6353,567,305Aug 13
Logan Thomas DChief Executive OfficerAug 11 '25Sale21.31325,0006,927,1483,742,305Aug 13
Eloy LoicNuclear & Safety PresidentAug 05 '25Sale21.3022,166472,138142,770Aug 06
Schopfer BrianChief Financial OfficerJun 25 '25Sale21.0075,0001,575,000919,432Jun 27
Kingsley Lawrence DDirectorMay 21 '25Sale17.94500,0008,972,3500May 23
Schopfer BrianChief Financial OfficerMay 21 '25Sale18.2775,0001,370,003919,432May 23
Eloy LoicTechnologies Group PresidentDec 13 '24Sale17.8944,000787,160133,663Dec 17
Lee EmmanuelleChief Legal OfficerOct 31 '24Sale14.273,40548,6030Nov 04
Logan Thomas DChief Executive OfficerOct 24 '24Sale14.117,500105,8150Oct 28
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.